Pathological Characterization and Risk Factors of Splenic Nodular Lesions in Dogs (Canis lupus familiaris)
Author:
Corvera Gloria1, Alegría-Morán Raúl2ORCID, Cifuentes Federico Francisco3ORCID, Torres Cristian Gabriel14ORCID
Affiliation:
1. Department of Clinical Sciences, Faculty of Animal and Veterinary Sciences, Universidad de Chile, Santiago 8820808, Chile 2. School of Veterinary Medicine, Faculty of Natural Resources and Veterinary Medicine, Universidad Santo Tomás, Santiago 8370003, Chile 3. Laboratory of Animal Pathology ESPA, Santiago 7510612, Chile 4. Centralized Veterinary Research Lab, Faculty of Animal and Veterinary Sciences, Universidad de Chile, Santiago 8820808, Chile
Abstract
In dogs, the spleen is a secondary lymphoid organ that can be affected by both neoplastic and non-neoplastic nodules. In general, few studies relate histopathological diagnosis to tumor size and the number of nodules in spleen biopsies. Some of these studies are inconclusive regarding the difference between neoplastic and non-neoplastic lesions and have small sample sizes or do not consider all splenic lesions. This study aimed to characterize splenic masses and determine risk factors for spleen tumors in dogs. A total of 507 histological reports corresponding to the diagnosis of splenic lesions in dogs from a private laboratory of animal pathology in the Metropolitan Region, Chile, were used. Data were analyzed by descriptive statistics and multiple logistic regression. The most frequent neoplastic and non-neoplastic diagnoses were hemangiosarcoma and hyperplasia, respectively. Most of the cases occurred in male (265 cases, 52.3%), senior (421 cases, 83%), and purebred individuals (342 cases, 67.5%). The most affected breeds were the Cocker Spaniel, German Shepherd, and Labrador Retriever. The most frequent lesion was a single nodule. The variables that exhibited a greater risk for the presentation of splenic neoplasia were male sex (odds ratio (OR) = 16.21; 95% confidence interval (CI) 1.741–150.879; p = 0.014), the presence of two or more splenic nodules (OR = 3.94; 95% CI 2.168–7.177; p < 0.001), an increase in nodule size greater than 2 cm (OR for quartiles 2, 3 and 4 of 2.2; 95% CI 1.036–4.941; p = 0.041, 2.9; 95% CI 1.331–6.576; p = 0.008, and 3.6; 95% CI 1.562–8.499; p = 0.003, respectively), and increasing age (OR = 1.23; 95% CI 1.048–1.436; p = 0.011). On the other hand, males exhibited a lower risk as age increases (OR = 0.76; 95% CI 0.615–0.928; p = 0.008). In conclusion, this study identified that males, multinodular presentation, nodule size, and age are risk factors for the occurrence of splenic neoplasia in dogs, knowledge that will contribute to the diagnostic management of dogs with spleen lesions.
Reference41 articles.
1. Canine splenic pathology: A retrospective study of 109 surgical samples, with special emphasis on fibrohistiocytic nodules;Bettini;Eur. J. Vet. Pathol.,2001 2. Canine indolent nodular lymphoma;Valli;Vet. Pathol.,2006 3. Clinical Characteristics and Outcome in Dogs with Splenic Marginal Zone Lymphoma;Moore;J. Vet. Intern. Med.,2013 4. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes;Stewart;Vet. Comp. Oncol.,2020 5. De Nardi, A.B., de Oliveira Massoco Salles Gomes, C., Fonseca-Alves, C.E., de Paiva, F.N., Linhares, L.C.M., Carra, G.J.U., Dos Santos Horta, R., Ruiz Sueiro, F.A., Jark, P.C., and Nishiya, A.T. (2023). Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET. Cancers, 15.
|
|